Introduction: The aim of the study was to evaluate the association of masked uncontrolled hypertension (MUCH) and prevalence of cardiovascular disease in treated hypertensive patients.
Material and methods: Patients' demographics and prior medical histories were collected. Fasting venous blood was drawn for evaluation of serum creatinine level, which was used to calculate glomerular filtration rate (GFR). Clinic blood pressure (BP) and 24 h ambulatory blood pressure monitoring (ABPM) measurements were performed. Based on the clinic BP and 24 h ABPM results, patients were divided into MUCH and non-masked hypertension groups.
Results: Compared to patients without masked hypertension, MUCH patients were older (62.4 ±11.2 vs. 59.7 ±10.4 years, p < 0.05), more likely to be male (66.9% vs. 63.4%), had diabetes (33.9% vs. 29.6%), longer hypertension duration (12.4 ±5.3 vs. 9.5 ±4.5 years, p < 0.05), lower GFR (79.5 ±11.6 vs. 82.4 ±10.3 ml/min/1.73 m2, p < 0.05), treated with β-blocker (39.0% vs. 32.7%, p < 0.05) and required more antihypertensive medications (2.7 ±0.5 vs. 2.2 ±0.3, p < 0.05). MUCH patients have higher cardiovascular disease prevalence than that without masked hypertension (30.1% vs. 23.4%, p < 0.05). After adjustment for covariates, MUCH was still independently associated with higher cardiovascular disease prevalence with odds ratio 1.38 (95% confidence interval 1.17-1.62, p < 0.05).
Conclusions: The MUCH is independently associated with prevalent cardiovascular disease in treated hypertensive patients. Future studies are needed to evaluate whether correction of MUCH can improve patients' outcomes.
Keywords: association; cardiovascular diseases; masked hypertension.
Copyright: © 2019 Termedia & Banach.
Conflict of interest statement
The authors declare no conflict of interest.
Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH).Med Arch. 2016 Jul 27;70(4):274-279. doi: 10.5455/medarh.2016.70.274-279. Med Arch. 2016. PMID: 27703288 Free PMC article.
High prevalence of masked uncontrolled hypertension in people with treated hypertension.Eur Heart J. 2014 Dec 7;35(46):3304-12. doi: 10.1093/eurheartj/ehu016. Epub 2014 Feb 3. Eur Heart J. 2014. PMID: 24497346 Clinical Trial.
Masked uncontrolled hypertension: Prevalence and predictors.Egypt Heart J. 2018 Dec;70(4):369-373. doi: 10.1016/j.ehj.2018.10.001. Epub 2018 Oct 22. Egypt Heart J. 2018. PMID: 30591757 Free PMC article.
Screening for High Blood Pressure in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Dec. Report No.: 13-05194-EF-1. Agency for Healthcare Research and Quality (US). 2014. PMID: 25632496 Free Books & Documents. Review.
Relationship Between Outpatient Clinic and Ambulatory Blood Pressure Measurements and Mortality.Curr Cardiol Rep. 2019 Mar 18;21(5):28. doi: 10.1007/s11886-019-1114-z. Curr Cardiol Rep. 2019. PMID: 30880364 Review.
- Zanchetti A, Liu L, Mancia G, et al. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. J Hypertens. 2014;32:1888–97. - PubMed
- Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project) Lancet. 2017;390:2549–58. - PubMed
- Salles GF, Leite NC, Pereira BB, Nascimento EM, Cardoso CR. Prognostic impact of clinic and ambulatory blood pressure components in high-risk type 2 diabetic patients: the Rio de Janeiro type 2 Diabetes Cohort Study. J Hypertens. 2013;31:2176–86. - PubMed
- Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects in patients at different levels of cardiovascular risk: overview and meta-analyses of randomized trials. J Hypertens. 2014;32:2305–14. - PubMed